Earnings360 Newsletter for 9/26/2024

Every breakthrough in precision medicine, diagnostics, and drug development relies on high-quality human biospecimens. Yet today's supply chain is slow, fragmented, and relationship-driven. Researchers often wait 6 to 12 months just to secure sourcing agreements, facing delays, inconsistent availability, and complex compliance hurdles. Meanwhile, hospitals and labs struggle to monetize specimens they already collect. iSpecimen Inc. (NASDAQ: ISPC) is quietly revolutionizing this broken system through its cloud-based iSpecimen Marketplace, connecting life science researchers directly with providers through a compliant, searchable, global platform. The global biospecimen market is estimated at $3 to $4 billion and growing 10 to 15% annually. As a first-mover with a scalable, cloud-based marketplace, ISPC is uniquely positioned to capture market share. In early 2026, ISPC sourced 500 influenza swab samples in just weeks for a time-sensitive research project. With 105+ supplier organizations, 600+ unique customer organizations, and nearly 7,600 marketplace users, ISPC is building the infrastructure that modern biomedical research needs.